This is a federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a ceiling value of $1,200,000.00. The contract is for the delivery of the radiopharmaceuticals PLUVICTO and LUTATHERA, which are used in cancer treatment and diagnostic imaging. The contract has a performance period ending on February 16, 2026 and was awarded on February 17, 2025. The contract is not set aside for small businesses. Advanced Accelerator Applications USA Inc. is a subsidiary of Novartis and has been providing specialized radiopharmaceutical products to federal healthcare agencies, including the Department of Veterans Affairs (VA), Defense Health Agency (DHA), and National Institutes of Health (NIH), since 2004.
Generated 3/8/25, 9:50 AM